Pura Vida Investments’s Labcorp LH Stock Holding History

Pura Vida Investments’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-75,660	Closed	-$10M	–	86
2017 Q2	$10M	Buy	+75,660	New	+$9.27M	3.98%	5

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pura Vida Investments's LH Position: Q3 2017 in Review

Pura Vida Investments sold out of Labcorp (LH) in Q3 2017, closing a stake of 75,660 shares — an estimated $10M sold.

Pura Vida Investments first reported a position in LH in Q2 2017 and held it in 1 quarter. The position peaked at $10M in Q2 2017. 701 funds tracked by Wall St. Rank hold LH as of Q3 2017.

Pura Vida Investments reported no remaining Labcorp position as of Q3 2017 after selling out during the quarter.
Pura Vida Investments sold 75,660 Labcorp shares in Q3 2017, an estimated $10M.
Pura Vida Investments first reported a position in Labcorp in Q2 2017 and held it in 1 quarter.
Pura Vida Investments's Labcorp position peaked at $10M in Q2 2017.
701 funds tracked by Wall St. Rank held Labcorp as of Q3 2017.

Based on Pura Vida Investments's 13F filing for Q3 2017, filed 14 Nov 2017.